RT @CIC1432dijon: étude LYMPHONIE du @CHUDijon publiée ! Réponse immunitaire COVID-19 vs autre cause de pneumopathie. Des particularités i…
RT @CIC1432dijon: @CHUDijon LYMPHONIE study published ! Immune response in COVID-19 vs other pulmonary infections. Difference in Cytokines…
RT @CIC1432dijon: étude LYMPHONIE du @CHUDijon publiée ! Réponse immunitaire COVID-19 vs autre cause de pneumopathie. Des particularités i…
Beau travail !
RT @CIC1432dijon: @CHUDijon LYMPHONIE study published ! Immune response in COVID-19 vs other pulmonary infections. Difference in Cytokines…
RT @CIC1432dijon: @CHUDijon LYMPHONIE study published ! Immune response in COVID-19 vs other pulmonary infections. Difference in Cytokines…
RT @CIC1432dijon: étude LYMPHONIE du @CHUDijon publiée ! Réponse immunitaire COVID-19 vs autre cause de pneumopathie. Des particularités i…
RT @CIC1432dijon: étude LYMPHONIE du @CHUDijon publiée ! Réponse immunitaire COVID-19 vs autre cause de pneumopathie. Des particularités i…
@CHUDijon LYMPHONIE study published ! Immune response in COVID-19 vs other pulmonary infections. Difference in Cytokines assays associated with ventilation duration. https://t.co/ZhyLGLV7H9
RT @CIC1432dijon: étude LYMPHONIE du @CHUDijon publiée ! Réponse immunitaire COVID-19 vs autre cause de pneumopathie. Des particularités i…
étude LYMPHONIE du @CHUDijon publiée ! Réponse immunitaire COVID-19 vs autre cause de pneumopathie. Des particularités immunitaires au cours de la COVID-19 associées à la durée de ventilation. De nouveaux biomarqueurs ouvrant des voies thérapeutiques ?
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
@ThinkFinance999 @Bullltalk @InkridgeC Science > Opinion ⬆️ GM-CSF & CXCL10 in COVID-19 patients were independently associated w longer duration of mechanical ventilation. "These cytokines could represent the dysregulated immune response in severe
The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. https://t.co/cQKPCt8pqo
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
$HGEN
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
@brucep13 GM CSF. IL 10. Main elevators in mechanical vent patients!!! So many studies!!! Just keeps adding https://t.co/wr4PGDI0yF
More studies support GM-CSF for severe patients. #lenzilumab Humanigen. Save lives and prevent post COViD syndrome! https://t.co/wr4PGDI0yF
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
RT @humanigen: Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate,…
Independent studies point to the role of GM-CSF in #COVID19, underscoring potential for our P3 investigational Tx candidate, Lenzilumab. P3 trial enrollment is at 425 patients & counting as we maintain our commitment to delivering much-needed therapeut
RT @gtflkind: $HGEN +40% this week = just the start.
$HGEN +40% this week = just the start.
RT @AlphaTrader00: "A unique cytokine response, with higher plasma GM-CSF & CXCL10 in COVID-19 patients..were independently associated with…
RT @AlphaTrader00: "A unique cytokine response, with higher plasma GM-CSF & CXCL10 in COVID-19 patients..were independently associated with…
"A unique cytokine response, with higher plasma GM-CSF & CXCL10 in COVID-19 patients..were independently associated with the longer duration of mechanical ventilation." These cytokines could represent promising therapeutic targets 👀 $HGEN #Lenzilumab
RT @ian_9r3t3: $HGEN Targeted therapies likely to dampen the dysregulated immune response in COVID-19 are urgently needed. Specifically, GM…
$HGEN Targeted therapies likely to dampen the dysregulated immune response in COVID-19 are urgently needed. Specifically, GM-CSF blockade (e.g. with lenzilumab) is increasingly being considered as a promising therapy in COVID-19. https://t.co/6jOk4EiS3e